News

India faces its quietest health challenge—calcium deficiency. Despite calcium's crucial role in bone health and muscle function, a significant number of Indians fail to meet the recommended ...
NEW DELHI: India's drug regulator flagged select batches of four drugs, including commonly used calcium supplement Shelcal 500 and antacid Pan D, as spurious on Friday. In its latest monthly drug ...
Shelcal 500, PAN-40, Paracetamol, 46 other drugs fail quality test. Do you consume? Check list here The Central Drug Regulatory Authority flagged four drugs as spurious and identified 49 others as ...
New Delhi: The Central Drug Regulatory Authority (CDRA) had raised significant concerns regarding the quality of pharmaceutical products available in the market. The commonly used calcium ...
Commonly used calcium supplement Shelcal 500 and antacid Pan D are among the four drugs flagged as spurious . IANSUpdated: Saturday, October 26, 2024, 01:01 PM IST. Canva.
The Central Drug Regulatory Authority has identified four drugs, including popular calcium supplement Shelcal 500 and Pan D, as spurious. Additionally, 49 drug samples were deemed "Not of Standard ...
Urimax-D: Used for managing non-cancerous prostate enlargement. Shelcal 500: Calcium and Vitamin D3 Tablets, a dietary supplement critical for maintaining bone health. Nandrolone Decanoate ...
Torrent Pharmaceuticals on Tuesday said it has forayed into the over-the-counter segment in the country with Shelcal 500, a calcium supplement brand. With its composition of 500mg Calcium and 250 ...
More than 53 commonly used medicines including Paracetamol and Shelcal, fail the drug regulator's quality test. ( Source : Deccan Chronicle ) Central Drugs Standards Control Organisation CDSCO NSQ .
It is worth mentioning that besides Paracetamol, drugs like vitamin C and D3 tablets, Shelcal, vitamin B complex, vitamin C softgels, Pan-D, Glimepiride and Telmisartan, have also made the NSQ ...
Shelcal 500, PAN-D, Paracetamol, 46 other drugs fail quality test. Nation. DC Correspondent. 27 Oct 2024 5:41 PM IST. x. Representational Image. New Delhi: The Central Drug Regulatory Authority ...